2005
DOI: 10.1099/vir.0.81249-0
|View full text |Cite
|
Sign up to set email alerts
|

Coxsackie B virus infection of mice: inoculation by the oral route protects the pancreas from damage, but not from infection

Abstract: The pathogenesis of coxsackie B virus (CVB) infections is generally studied in mice by intraperitoneal (i.p.) injection, whereas the gastrointestinal tract is the natural porte d'entrée in humans. The present study was undertaken to compare systematically the influence of infection route on morbidity and pathology. Swiss Albino mice were infected with CVB3 (Nancy) at different doses (5 x 10(3), 5 x 10(5), 5 x 10(7), 5 x 10(9) TCID50), given either i.p. or orally. Virus could be isolated from several organs (he… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
63
2

Year Published

2009
2009
2017
2017

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 47 publications
(68 citation statements)
references
References 40 publications
3
63
2
Order By: Relevance
“…injection models bypass the first stage of infection in the gastrointestinal tract. Relatively few studies have used oral inoculation of mice with coxsackievirus (19)(20)(21)(22)(23). Therefore, CVB3 replication and factors that influence viral replication in the intestine remain poorly understood.…”
mentioning
confidence: 99%
“…injection models bypass the first stage of infection in the gastrointestinal tract. Relatively few studies have used oral inoculation of mice with coxsackievirus (19)(20)(21)(22)(23). Therefore, CVB3 replication and factors that influence viral replication in the intestine remain poorly understood.…”
mentioning
confidence: 99%
“…Although infection can be established by the enteral (oral [p.o.]) route in some murine models (15,16), the gastrointestinal tract has been reported to act as a barrier to infection, particularly beyond the neonatal period (17). Consistent with the idea of an intestinal barrier, our own experience has been that infection by the enteral route requires virus doses much higher (10,000-fold or more) than those needed to infect mice by intraperitoneal injection (unpublished data; see Fig.…”
mentioning
confidence: 99%
“…In fact, a single inoculation of the mutant Sabin3-like by i.p route protected all mice challenged 16 days later with a virulent CVB3 and CVB4 E2 which induced, respectively, myocarditis and pancreatitis in the unprotected control mice. Heart and pancreatic damages due to viral CVB3 and CVB4 replication have been demonstrated to be clearly evident at 10 days post-infection (Tracy et al 1992;Tu et al 1995;Bopegamage et al 2003Bopegamage et al , 2005Jaidane et al 2006). However, one mouse immunized with the attenuated Sabin3-like strain, developed pancreatitis after challenge by i.p route with CVB4 E2.…”
Section: Discussionmentioning
confidence: 99%